Crossref
Epsolay - A Benzoyl Peroxide Cream for Rosacea
The Medical Letter on Drugs and Therapeutics · 2023
DOI: 10.58347/tml.2023.1669c ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2023. Hauptthemen laut MEDLINE: Rosacea, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
RosaceaDermatologic AgentsHumansBenzoyl PeroxideMetronidazoleAdministration, Cutaneous
Stichwörter der Autor:innen
EpsolayMetrogeladverse effectsazelaic acidbenzoyl peroxidedosagedoxycyclineefficacyivermectinlactationmetronidazoleminocyclinepregnancyrosaceasafety
Substanzen
Benzoyl PeroxideMetronidazoleDermatologic Agents
Zitieren
APA
(2023). Epsolay - A Benzoyl Peroxide Cream for Rosacea. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2023.1669c
Vancouver
Epsolay - A Benzoyl Peroxide Cream for Rosacea. The Medical Letter on Drugs and Therapeutics. 2023. doi:10.58347/tml.2023.1669c
BibTeX
@article{euvimed2023,
title = {Epsolay - A Benzoyl Peroxide Cream for Rosacea},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2023},
doi = {10.58347/tml.2023.1669c}
}
EUVIMED